Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1BMN 111----1件: 276 💬
2BMN 111 administration VIA injector PEN----1件: 276 💬
3BMN 111 administration VIA vial and syringe----1件: 276 💬
4C-type natriuretic peptide conjugated TO A multi-ARM polyethylene glycol carrier molecule through A cleavable linker----1件: 276 💬
5C-type natriuretic peptide conjugated TO multi-ARM polyethylene glycol carrier through A cleavable linker----1件: 276 💬
6Combination OF navepegritide and lonapegsomatropin administered AS TWO separate S.C. injections----1件: 276 💬
7Infigratinib1件: Infigratinib2件: Infigratinib ,
Infigratinib phosphate 💬 		3件: FGFR1,
FGFR2,
FGFR3 💬 		20件: Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Endocytosis, Gastric cancer, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells, Thermogenesis 💬1件: 276 💬
8Infigratinib 0.016 MG/KG1件: Infigratinib2件: Infigratinib ,
Infigratinib phosphate 💬 		3件: FGFR1,
FGFR2,
FGFR3 💬 		20件: Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Endocytosis, Gastric cancer, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells, Thermogenesis 💬1件: 276 💬
9Infigratinib 0.032 MG/KG1件: Infigratinib2件: Infigratinib ,
Infigratinib phosphate 💬 		3件: FGFR1,
FGFR2,
FGFR3 💬 		20件: Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Endocytosis, Gastric cancer, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells, Thermogenesis 💬1件: 276 💬
10Infigratinib 0.064 MG/KG1件: Infigratinib2件: Infigratinib ,
Infigratinib phosphate 💬 		3件: FGFR1,
FGFR2,
FGFR3 💬 		20件: Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Endocytosis, Gastric cancer, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells, Thermogenesis 💬1件: 276 💬
11Infigratinib 0.128 MG/KG1件: Infigratinib2件: Infigratinib ,
Infigratinib phosphate 💬 		3件: FGFR1,
FGFR2,
FGFR3 💬 		20件: Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Endocytosis, Gastric cancer, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells, Thermogenesis 💬1件: 276 💬
12Infigratinib 0.25 MG/KG1件: Infigratinib2件: Infigratinib ,
Infigratinib phosphate 💬 		3件: FGFR1,
FGFR2,
FGFR3 💬 		20件: Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Endocytosis, Gastric cancer, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells, Thermogenesis 💬1件: 276 💬
13Infigratinib 0.25 MG/KG/DAY1件: Infigratinib2件: Infigratinib ,
Infigratinib phosphate 💬 		3件: FGFR1,
FGFR2,
FGFR3 💬 		20件: Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Endocytosis, Gastric cancer, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells, Thermogenesis 💬1件: 276 💬
14Infigratinib phosphate1件: Infigratinib2件: Infigratinib ,
Infigratinib phosphate 💬 		3件: FGFR1,
FGFR2,
FGFR3 💬 		20件: Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Endocytosis, Gastric cancer, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells, Thermogenesis 💬1件: 276 💬
15KK8398----1件: 276 💬
16Modified recombinant human C-type----1件: 276 💬
17Modified recombinant human C-type natriuretic peptide----1件: 276 💬
18Modified rhcnp----1件: 276 💬
19Natriuretic peptide----1件: 276 💬
20Navepegritide----1件: 276 💬
21Normal saline----20件: 6, 13, 17, 22, 36, 46, 49, 60, 70, 94, 96, 97, 210, 211, 222, 226, 276, 280, 296, 299 💬
22PF-07256472----1件: 276 💬
23Recifercept1件: Recifercept1件: Recifercept 💬 1件: FGFR3 💬 12件: Bladder cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Endocytosis, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells 💬1件: 276 💬
24Recombinant human growth hormone1件: Somatotropin1件: Somatropin 💬 1件: GHR 💬 6件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬4件: 77, 193, 265, 276 💬
25SAR442501----1件: 276 💬
26Somatropin1件: Somatotropin1件: Somatropin 💬 1件: GHR 💬 6件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬18件: 2, 3, 19, 74, 75, 78, 96, 97, 107, 113, 187, 193, 195, 238, 265, 274, 276, 299 💬
27TA-461件: Recifercept1件: Recifercept 💬 1件: FGFR3 💬 12件: Bladder cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Endocytosis, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells 💬1件: 276 💬
28TBD----5件: 19, 86, 90, 276, 299 💬
29Transcon CNP1件: ACP-015---1件: 276 💬
30Transcon CNP 3.9 MG CNP-38/vial1件: ACP-015---1件: 276 💬
31TYRA-300 0.125 MG/KG----1件: 276 💬
32TYRA-300 0.25 MG/KG----1件: 276 💬
33TYRA-300 0.375 MG/KG----1件: 276 💬
34TYRA-300 0.50 MG/KG----1件: 276 💬
35Vorsoritide----1件: 276 💬
36Vosoritide1件: Vosoritide1件: Vosoritide 💬 1件: NPR2 💬 5件: Hormone signaling, Oxytocin signaling pathway, Purine metabolism, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬2件: 19, 276 💬
37Voxzogo1件: Vosoritide1件: Vosoritide 💬 1件: NPR2 💬 5件: Hormone signaling, Oxytocin signaling pathway, Purine metabolism, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 276 💬